4960.F BRAXIA SCIENTIFIC CORP.

Healthcare Biotechnology Frankfurt Exchange
0.0020 EUR
Close of Nov 11, 2026
0.0020 0.0020
Market cap
EUR 567K
P/E
-
P/B
3.60x
ROE
-818.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Mar 2023.

Is 4960.F undervalued?

Graham number

The Graham number of BRAXIA SCIENTIFIC CORP. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BRAXIA SCIENTIFIC CORP. fundamental analysis

No fundamental analysis for BRAXIA SCIENTIFIC CORP. yet.

BRAXIA SCIENTIFIC CORP. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BRAXIA SCIENTIFIC CORP.

Braxia Scientific Corp. operates as a medical research and telemedicine company with clinics that provide ketamine treatments for persons with depression and related disorders. It also operates a multidisciplinary clinic that offers treatments for depression. The company is based in Mississauga, Canada.

Full company profile